... carried out on 48,000 volunteers in their three-dose scheme, researchers from the Center for Genetic Engineering and Biotechnology (CIGB) point ...
https://www.google.com/url?rct=j&sa=t&url=https://marketresearchtelecast.com/cuban-vaccine-abdala-shows-100-efficacy-in-preventing-death-and-severe-illness-from-covid-19-in-phase-iii-trials/105059/&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNEF7tv8lgyhY4B2RGcMR58m9pBaYw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.